Human Myobundle Platform for Studying the Role of Notch Signaling in Satellite Cell Phenotype and Function
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Torie Broer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA. Hauptthemen laut MEDLINE: Receptors, Notch, Signal Transduction, Satellite Cells, Skeletal Muscle, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Notch signaling plays a pivotal role in regulating satellite cell (SC) behavior during skeletal muscle development, homeostasis, and repair. While well‐characterized in mouse models, the impact of Notch signaling in human muscle tissues remains largely underexplored. Here, a 3D tissue‐engineered model of human skeletal muscle (“myobundles”) is utilized as an in vitro platform for temporal control and studies of Notch singaling. Myofiber‐specific overexpression of the Notch ligand, DLL1, early in myobundle differentiation increases the abundance of 3D SCs and shifts their phenotype to a more quiescent‐like state, along with decreasing muscle mass and function. In contrast, myofiber‐specific DLL1 overexpression after one week of myobundle differentiation does not affect 3D SC abundance or muscle function, but increases transcriptomic markers of SC quiescence, confirming the temporal dependence of SC activation and self‐renewal on Notch signaling activity. Finally, for the first time these studies show that even after a transient, myofiber‐specific upregulation of Notch signaling in myobundles, 3D SCs expanded from these tissues can re‐form functional “secondary” myobundles containing an amplified SC pool. Future studies in the described human myobundle platform are expected to aid the development of novel Notch‐targeted therapies for muscular dystrophies and aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
- Department of Cell Biology, Duke University, Durham, NC, 27708, USA.
ORCID-Profile: Torie Broer, Abbigail Helfer, Sophia DeLuca, Alastair Khodabukus, Nenad Bursac
Förderung
- NCATS NIH HHS
- NIH HHS
- NIAMS NIH HHS
- NIGMS NIH HHS
- NIBIB NIH HHS
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Broer, T., Tsintolas, N., Hammond, S., Helfer, A., Lee, J., Purkey, K., DeLuca, S., Khodabukus, A., & Bursac, N. (2025). Human Myobundle Platform for Studying the Role of Notch Signaling in Satellite Cell Phenotype and Function. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404695
Vancouver
Broer T, Tsintolas N, Hammond S, Helfer A, Lee J, Purkey K, et al. Human Myobundle Platform for Studying the Role of Notch Signaling in Satellite Cell Phenotype and Function. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404695
BibTeX
@article{Broer2025,
author = {Broer, Torie and Tsintolas, Nick and Hammond, Stewart and Helfer, Abbigail and Lee, Joonbum and Purkey, Karly and DeLuca, Sophia and Khodabukus, Alastair and Bursac, Nenad},
title = {Human Myobundle Platform for Studying the Role of Notch Signaling in Satellite Cell Phenotype and Function},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404695}
}
EUVIMED